Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Shares Repurchased (2017 - 2026)

Avanos Medical's Shares Repurchased history spans 9 years, with the latest figure at $300000.0 for Q4 2025.

  • On a quarterly basis, Shares Repurchased rose 200.0% to $300000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.3 million, a 74.22% decrease, with the full-year FY2025 number at $3.3 million, down 74.22% from a year prior.
  • Shares Repurchased hit $300000.0 in Q4 2025 for Avanos Medical, down from $800000.0 in the prior quarter.
  • Over the last five years, Shares Repurchased for AVNS hit a ceiling of $19.4 million in Q1 2022 and a floor of $100000.0 in Q3 2021.
  • Historically, Shares Repurchased has averaged $5.1 million across 5 years, with a median of $2.4 million in 2023.
  • Biggest five-year swings in Shares Repurchased: soared 10900.0% in 2022 and later plummeted 98.91% in 2024.
  • Tracing AVNS's Shares Repurchased over 5 years: stood at $10.9 million in 2021, then plummeted by 96.33% to $400000.0 in 2022, then surged by 1450.0% to $6.2 million in 2023, then plummeted by 98.39% to $100000.0 in 2024, then skyrocketed by 200.0% to $300000.0 in 2025.
  • Business Quant data shows Shares Repurchased for AVNS at $300000.0 in Q4 2025, $800000.0 in Q2 2025, and $2.2 million in Q1 2025.